
Centre Cuts Cancer Drug Rates; Supreme Court Asks Why Cap Isn't Expanded
What Happened?
The Centre has reduced prices of cancer drugs, prompting the Supreme Court to question why the price cap isn't expanded. This decision aims to make treatment more affordable for patients.
Key points
- The Centre has reduced prices of cancer drugs.
- The Supreme Court questioned the lack of expansion in the price cap.
- The decision aims to improve affordability for cancer treatment.
Key insights
- The price cut may lead to increased access to essential medications for cancer patients.
- Patients may benefit from reduced financial burden due to lower drug prices.
- The Supreme Court's inquiry could prompt further regulatory changes in drug pricing.
Why it matters
This decision could make cancer treatment more affordable for patients in India.
Entities
Source
India Today



